ExodusPoint Capital Management, LP
Position in KYMR — Kymera Therapeutics, Inc.
CIK 1736225
NEW YORK, NY
Position in KYMR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,358,606
-$2,048,903 QoQ
Shares Held
28,318
-72.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in KYMR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,358,606 | 28,318 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $4,407,509 | 100,997 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $807,442 | 29,501 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $568,288 | 14,126 | Shares | Sole | 2025-02-12 | |
| 2023-09-30 | $155,916 | 11,217 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,265,219 | 185,525 | Shares | Other | 2023-08-11 | |
| 2022-09-30 | $469,187 | 21,552 | Shares | Other | 2022-11-10 | |
| 2020-09-30 | $515,958 | 15,969 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||